Delaware VIP® Emerging Markets Series

Objective

Delaware VIP Emerging Markets Series seeks long-term capital appreciation.

Strategy

The Series invests primarily in a broad range of equity securities of companies located in emerging market countries.

Series information
Inception date05/01/2000
Dividends paid (if any)Annually
Capital gains paid (if any)Annually
Series identifier
CUSIP246493886

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.

Total returns may reflect waivers and/or expense reimbursements by the manager and/or distributor for some or all of the periods shown. Performance would have been lower without such waivers and reimbursements.

Average annual total return as of month-end (07/31/2014)
YTD1 year3 year5 year10 yearLifetimeInception date
NAV (view definition)5.63%16.52%2.76%8.80%11.90%12.01%05/01/2000
MSCI Emerging Markets Index (Gross)8.46%15.72%0.74%7.68%12.72%n/a
MSCI Emerging Markets Index (Net)8.19%15.32%0.40%7.34%12.36%n/a
Average annual total return as of quarter-end (06/30/2014)
QTDYTD1 year3 year5 year10 yearLifetimeInception date
NAV (view definition)8.01%4.88%20.53%1.85%10.94%12.12%12.03%05/01/2000
MSCI Emerging Markets Index (Gross)6.71%6.32%14.68%-0.06%9.58%12.30%n/a
MSCI Emerging Markets Index (Net)6.59%6.14%14.31%-0.39%9.24%11.94%n/a

Returns for less than one year are not annualized.

Expense ratio
Gross1.71%
Net1.66%

Net expense ratio reflects a contractual distribution fee waiver from April 30, 2014 to April 30, 2015. Please see the fee table in the Series' prospectus for more information.

The performance and expense ratio information shown represent the performance and fees as they relate to actual shares of the Series. These examples do not include any fees or sales charges imposed by the variable insurance contract for which the Series is an investment option. If they were included, your costs would be higher and performance would be lower. Investors should consult the contract prospectus or disclosure documents for more information.

Quarterly total returns @ NAV
Year1st quarter2nd quarter3rd quarter4th quarterAnnual return
2014-2.90%8.01%n/an/an/a
20131.42%-5.75%11.17%3.38%9.86%
201212.09%-10.85%7.16%6.63%14.19%
20112.26%-2.58%-24.11%5.82%-20.00%
20101.70%-10.13%17.36%10.21%18.21%
2009-1.87%34.04%23.89%9.03%77.67%
2008-10.16%1.67%-26.40%-28.13%-51.68%
20072.92%17.51%10.03%4.09%38.51%
20068.92%-5.83%4.63%18.17%26.81%
20051.91%4.33%16.13%2.95%27.11%
20047.68%-5.98%11.27%18.30%33.26%
Portfolio characteristics - as of 07/31/2014
Share assets$411.4 million
Number of holdings131
Market cap (median)$7.87 billion
Market cap (weighted average)$40.51 billion
Portfolio turnover (last fiscal year)16%
Beta (relative to MSCI Emerging Markets Index (Gross)) (view definition)0.97
Annualized standard deviation, 3 years (view definition)19.40
Portfolio composition as of 07/31/2014Total may not equal 100% due to rounding.
International equities & depository receipts100.7%
Domestic equities1.5%
Cash and cash equivalents-2.1%
Top 10 holdings as of 07/31/2014
Holdings are as of the date indicated and subject to change.
List excludes cash and cash equivalents.
Holding% of portfolio
Baidu Inc.5.4%
SK Telecom Co. Ltd.3.1%
Samsung Electronics Co. Ltd.3.0%
Teva Pharmaceutical Industries Ltd.2.7%
Grupo Televisa SAB2.6%
Reliance Industries Ltd.2.4%
Tim Participacoes S.A.2.2%
Reliance Industries Ltd.2.2%
Cemex SAB de CV2.1%
Sohu.com Inc.1.9%
Total % Portfolio in Top 10 holdings27.6%
Top 10 countries as of 07/31/2014List excludes cash and cash equivalents.
Country% of portfolio
China19.4%
South Korea17.0%
Brazil16.8%
Mexico8.5%
Russia8.3%
Taiwan7.3%
India5.5%
South Africa4.0%
Argentina3.5%
Israel2.7%
Liu-Er Chen

Liu-Er Chen, CFA

Senior Vice President, Chief Investment Officer — Emerging Markets and Healthcare

Start date on the Fund: September 2006

(View bio)


The following table describes the fees and expenses that you may pay if you buy and hold shares of the Series. The fee table does not reflect any fees or sales charges imposed by variable insurance contracts. If it did, the expenses would be higher.

Annual series operating expenses
Management fees1.25%
Distribution and service (12b-1) fees0.30%
Other expenses0.16%
Total annual series operating expenses1.71%
Fee waivers and expense reimbursements(0.05%)
Total annual series operating expenses after fee waivers and expense reimbursements1.66%

1The Series' distributor, Delaware Distributors, L.P. (Distributor), has contracted to limit the 12b-1 fees to no more than 0.25% of average daily net assets from April 30, 2014 through April 30, 2015. This waiver may be terminated only by agreement of the Distributor and the Series.

Carefully consider the Series' investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Series' prospectus and its summary prospectus, which may be obtained by clicking the prospectus link located in the right-hand sidebar or by calling 800 523-1918. Investors should read the prospectus and the summary prospectus carefully before investing.

Investing involves risk, including the possible loss of principal.

International investments entail risks not ordinarily associated with U.S. investments including fluctuation in currency values, differences in accounting principles, or economic or political instability in other nations.

Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility and lower trading volume.

The Series is distributed by Delaware Distributors L.P., an affiliate of Delaware Management Holdings, Inc., and Macquarie Group Limited.

Delaware VIP Series refers to Delaware VIP Funds. Delaware VIP Funds are not available for direct investment except for issuers of variable insurance product contracts. They are only available through the purchase of certain variable insurance products.

Fund Finder

Daily pricing (as of 08/29/2014)

Service ClassPriceNet changeYTD
NAV$23.100.048.79%
Max offer price$23.10n/an/a

Total net assets (as of 07/31/2014)

$599.4 million all share classes

Benchmark, peer group

MSCI Emerging Markets Index (view)

Lipper Emerging Markets Funds Average (view)

Additional information